195 related articles for article (PubMed ID: 31972324)
1. The characteristics and regularities of cardiac adverse drug reactions induced by Chinese materia medica: A bibliometric research and association rules analysis.
Zhang D; Lv J; Zhang B; Zhang X; Jiang H; Lin Z
J Ethnopharmacol; 2020 Apr; 252():112582. PubMed ID: 31972324
[TBL] [Abstract][Full Text] [Related]
2. The rise of traditional Chinese medicine and its materia medica: a comparison of the frequency and safety of materials and species used in Europe and China.
Williamson EM; Lorenc A; Booker A; Robinson N
J Ethnopharmacol; 2013 Sep; 149(2):453-62. PubMed ID: 23832055
[TBL] [Abstract][Full Text] [Related]
3. Review on Processing Methods of Toxic Chinese Materia Medica and the Related Mechanisms of Action.
Pan L; Wang Y; Yue L; Wang N; Xu W; Liao X; Wang H; Xiu Y
Am J Chin Med; 2023; 51(6):1385-1412. PubMed ID: 37545180
[TBL] [Abstract][Full Text] [Related]
4. Toxicological risks of Chinese herbs.
Shaw D
Planta Med; 2010 Dec; 76(17):2012-8. PubMed ID: 21077025
[TBL] [Abstract][Full Text] [Related]
5. Review of adverse reactions to injections of Chinese materia medica.
Bian Z; Shang H; Cheng C; Wu T; Li Y; Zhang B
J Evid Based Med; 2010 May; 3(2):88-94. PubMed ID: 21349050
[TBL] [Abstract][Full Text] [Related]
6. The Diagnosis and Management of Allergic Reactions Caused by Chinese Materia Medica.
Shi Y; Tang R; Luo F; Li H; Pan Z; Xu G; Yang Y; Zhao Z; Liang A; Wei JF; Piao Y; Chang C; Sun JL; Platts-Mills TAE
Clin Rev Allergy Immunol; 2022 Feb; 62(1):103-122. PubMed ID: 33606192
[TBL] [Abstract][Full Text] [Related]
7. An overview on adverse drug reactions to traditional Chinese medicines.
Chan K; Zhang H; Lin ZX
Br J Clin Pharmacol; 2015 Oct; 80(4):834-43. PubMed ID: 25619530
[TBL] [Abstract][Full Text] [Related]
8. Economic botany collections: A source of material evidence for exploring historical changes in Chinese medicinal materials.
Brand E; Leon C; Nesbitt M; Guo P; Huang R; Chen H; Liang L; Zhao Z
J Ethnopharmacol; 2017 Mar; 200():209-227. PubMed ID: 28219727
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacovigilance in materia medica works of Qing Dynasty].
Qu CC; Zhang B; Lin ZJ; Zhang XM; Zou LN
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(21):4751-4755. PubMed ID: 31872674
[TBL] [Abstract][Full Text] [Related]
10. UHPLC/Q-TOFMS-based metabolomics for the characterization of cold and hot properties of Chinese materia medica.
Wang Y; Zhou S; Wang M; Liu S; Hu Y; He C; Li P; Wan JB
J Ethnopharmacol; 2016 Feb; 179():234-42. PubMed ID: 26747020
[TBL] [Abstract][Full Text] [Related]
11. [Reduction of ADRs of essential traditional Chinese medicines].
Nie Q; Liu Y; Chen J
Zhongguo Zhong Yao Za Zhi; 2016 Jan; 41(2):340-344. PubMed ID: 28861983
[TBL] [Abstract][Full Text] [Related]
12. Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials.
Cheng CW; Bian ZX; Li YP; Moher D; Wu TX; Dagenais S; Li J; Li TQ
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):881-6. PubMed ID: 18782527
[TBL] [Abstract][Full Text] [Related]
13. [A glance at the property of acupoints--analysis on functions of acupoints in view of actions of Chinese materia medica].
Wang J; Zhao JP
Zhen Ci Yan Jiu; 2008 Aug; 33(4):280-3. PubMed ID: 18928124
[TBL] [Abstract][Full Text] [Related]
14. [The main factors influencing the toxicity of Chinese materia medica].
Tang YX
Zhongguo Zhong Yao Za Zhi; 1993 Feb; 18(2):117-20, 128. PubMed ID: 8323697
[TBL] [Abstract][Full Text] [Related]
15. Quality and safety of Chinese herbal medicines guided by a systems biology perspective.
Wang J; van der Heijden R; Spruit S; Hankermeier T; Chan K; van der Greef J; Xu G; Wang M
J Ethnopharmacol; 2009 Oct; 126(1):31-41. PubMed ID: 19683045
[TBL] [Abstract][Full Text] [Related]
16. The treatment of asthma using the Chinese Materia Medica.
Liu JX; Zhang Y; Yuan HY; Liang J
J Ethnopharmacol; 2021 Apr; 269():113558. PubMed ID: 33186702
[TBL] [Abstract][Full Text] [Related]
17. Advances in research into the mechanisms of Chinese Materia Medica against acute lung injury.
Ding Z; Zhong R; Xia T; Yang Y; Xing N; Wang W; Wang Y; Yang B; Sun X; Shu Z
Biomed Pharmacother; 2020 Feb; 122():109706. PubMed ID: 31918277
[TBL] [Abstract][Full Text] [Related]
18. [Data-mining characteristics of adverse drug reactions and pharmacovi-gilance of Chinese patent drugs including Aconitum herbs].
Zhang XM; Li F; Zhang B; Chen XF; Piao JZ
Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(2):216-221. PubMed ID: 29552835
[TBL] [Abstract][Full Text] [Related]
19. The classification and application of toxic Chinese materia medica.
Liu X; Wang Q; Song G; Zhang G; Ye Z; Williamson EM
Phytother Res; 2014 Mar; 28(3):334-47. PubMed ID: 23722570
[TBL] [Abstract][Full Text] [Related]
20. Analysis on the current quality standards of Chinese materia Medica used in COVID-19 prevention and treatment.
Shi YH; Huang YF; Wang WY; Yang L; Zhou H; Sang Z
Pharmacol Res; 2020 Oct; 160():105074. PubMed ID: 32653649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
